SG11201505538QA - Short bio-active peptides for promoting wound healing - Google Patents

Short bio-active peptides for promoting wound healing

Info

Publication number
SG11201505538QA
SG11201505538QA SG11201505538QA SG11201505538QA SG11201505538QA SG 11201505538Q A SG11201505538Q A SG 11201505538QA SG 11201505538Q A SG11201505538Q A SG 11201505538QA SG 11201505538Q A SG11201505538Q A SG 11201505538QA SG 11201505538Q A SG11201505538Q A SG 11201505538QA
Authority
SG
Singapore
Prior art keywords
wound healing
active peptides
promoting wound
short bio
bio
Prior art date
Application number
SG11201505538QA
Other languages
English (en)
Inventor
Lijuan Zhang
Robin Carmichael
Original Assignee
Helix Biomedix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helix Biomedix Inc filed Critical Helix Biomedix Inc
Publication of SG11201505538QA publication Critical patent/SG11201505538QA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1021Tetrapeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Birds (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Insects & Arthropods (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
SG11201505538QA 2013-02-14 2014-01-21 Short bio-active peptides for promoting wound healing SG11201505538QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361764913P 2013-02-14 2013-02-14
PCT/US2014/012378 WO2014126681A1 (fr) 2013-02-14 2014-01-21 Peptides bioactifs courts pour favoriser la cicatrisation d'une plaie

Publications (1)

Publication Number Publication Date
SG11201505538QA true SG11201505538QA (en) 2015-08-28

Family

ID=50069319

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201505538QA SG11201505538QA (en) 2013-02-14 2014-01-21 Short bio-active peptides for promoting wound healing

Country Status (24)

Country Link
US (2) US9487558B2 (fr)
EP (1) EP2956155B1 (fr)
JP (1) JP6348126B2 (fr)
KR (1) KR101894829B1 (fr)
CN (1) CN105120884B (fr)
AR (1) AR094835A1 (fr)
AU (1) AU2014216730B2 (fr)
BR (1) BR112015019568A2 (fr)
CA (1) CA2898717C (fr)
CY (1) CY1119087T1 (fr)
DK (1) DK2956155T3 (fr)
ES (1) ES2633437T3 (fr)
HK (1) HK1212243A1 (fr)
HU (1) HUE033976T2 (fr)
MX (1) MX363955B (fr)
MY (1) MY173174A (fr)
NZ (1) NZ711281A (fr)
PL (1) PL2956155T3 (fr)
RU (1) RU2606753C1 (fr)
SG (1) SG11201505538QA (fr)
SI (1) SI2956155T1 (fr)
TW (1) TWI587867B (fr)
WO (1) WO2014126681A1 (fr)
ZA (1) ZA201505516B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017200659A2 (fr) * 2016-04-08 2017-11-23 Cornell University Procédé pour améliorer la cicatrisation de plaies à l'aide de protéines dérivées de la soie
EP3312608B1 (fr) * 2016-10-24 2019-10-02 Akribes Biomedical GmbH Procédés d'identification d'une plaie cutanée non cicatrisante et de surveillance de la cicatrisation d'une plaie cutanée
US10232009B1 (en) * 2017-09-29 2019-03-19 Pro Sunfun Biotech Research And Development Co., Ltd. Peptide for promoting wound healing, its composition and method of using the same
CN108586575B (zh) * 2018-04-11 2020-08-14 福建省中科生物股份有限公司 一种多肽及其皮肤修复功能的应用
CZ308845B6 (cs) * 2019-01-21 2021-07-07 Globetech Innovation S.R.O Farmaceutická směs topicky hojivých peptidových složek pro použití k topické léčbě kožních defektů a/nebo k topickému hojení ran
CN116407611A (zh) * 2021-12-29 2023-07-11 四川好医生攀西药业有限责任公司 一种多肽在制备预防或治疗皮肤损伤疾病产品上的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6360939A (ja) * 1986-08-29 1988-03-17 Shin Etsu Chem Co Ltd 抗菌物質
EP0383770B1 (fr) 1987-07-06 1995-09-13 Louisiana State University and Agricultural and Mechanical College Inhibition de pathogenes et de neoplasmes eucaryotiques avec des peptides lytiques
US5861478A (en) 1987-07-06 1999-01-19 Helix Biomedix, Inc. Lytic peptides
JP5535620B2 (ja) * 2006-06-13 2014-07-02 ヘリックス バイオメディックス,インコーポレイテッド 細胞外マトリックスタンパク質の合成を誘導するペプチドフラグメント
US7696174B2 (en) * 2007-01-05 2010-04-13 Helix Biomedix, Inc. Short bio-active peptides for cellular and immunological modulation
RU2447896C1 (ru) * 2010-11-15 2012-04-20 Общество с ограниченной ответственностью "Аллофарм" Антимикробное вещество
CA2846629C (fr) 2011-08-25 2023-08-01 University Of Central Florida Research Foundation, Inc. Procedes et compositions renfermant un peptide derive de l'extremite c terminale de bax

Also Published As

Publication number Publication date
EP2956155A1 (fr) 2015-12-23
TW201446258A (zh) 2014-12-16
AU2014216730B2 (en) 2015-12-17
MX2015009404A (es) 2016-10-07
HK1212243A1 (en) 2016-06-10
ZA201505516B (en) 2016-10-26
JP6348126B2 (ja) 2018-06-27
CY1119087T1 (el) 2018-01-10
RU2606753C1 (ru) 2017-01-10
MX363955B (es) 2019-04-08
AR094835A1 (es) 2015-09-02
US20170000848A1 (en) 2017-01-05
CN105120884A (zh) 2015-12-02
KR20150116883A (ko) 2015-10-16
JP2016513107A (ja) 2016-05-12
TWI587867B (zh) 2017-06-21
KR101894829B1 (ko) 2018-09-05
CA2898717C (fr) 2019-01-08
HUE033976T2 (en) 2018-02-28
BR112015019568A2 (pt) 2017-08-22
AU2014216730A1 (en) 2015-08-20
CN105120884B (zh) 2017-08-29
MY173174A (en) 2020-01-02
EP2956155B1 (fr) 2017-04-19
WO2014126681A1 (fr) 2014-08-21
PL2956155T3 (pl) 2017-09-29
ES2633437T3 (es) 2017-09-21
DK2956155T3 (en) 2017-07-31
US20150353605A1 (en) 2015-12-10
SI2956155T1 (sl) 2017-10-30
NZ711281A (en) 2017-12-22
CA2898717A1 (fr) 2014-08-21
US9487558B2 (en) 2016-11-08

Similar Documents

Publication Publication Date Title
IL245744A0 (en) Therapeutic peptides
HK1219221A1 (zh) 用於傷口治療的敷料
HK1219983A1 (zh) 治療性肽
HK1214829A1 (zh) 治療肽
GB2516340B (en) Wound dressings
RS56954B1 (sr) Sistem zavoja
HK1212243A1 (en) Short bio-active peptides for promoting wound healing
EP2921148A4 (fr) Pansement pour la cicatrisation de plaies compromises
HRP20180452T1 (hr) Peptidi
HK1211596A1 (en) Peptide
HK1211595A1 (en) Peptide
EP2959912A4 (fr) Agent de cicatrisation de plaie
GB201315130D0 (en) Peptides
PL3021877T3 (pl) Opatrunek na ranę
GB201304973D0 (en) Recombinant protein
GB201308860D0 (en) Delivery peptides
TH1501004391A (th) เปปไทด์ออกฤทธิ์ทางชีวภาพสายสั้นสำหรับส่งเสริมการรักษาบาดแผล
AU2013904401A0 (en) Wound healing agents
GB201316660D0 (en) Peptides
TWM476584U (en) Wound dressings
GB201300381D0 (en) Peptides
GB201305465D0 (en) Novel peptides